| Klaus, Here you go-And Ed, read : Less Fat than Glue Farge:(( And the Side Effects is why I am here )) Glucophage
 Eat Broccoli or Take Muscle Cell Builder, rather than a Fat Cell Builder:
 healthyideas.com
 What Worries Me- The Big "O" < Olestra > < BTW- I WON't TOUCH it and I am a Big Rounded Guy!)Fat Question of this Century:
 healthyideas.com
 Fat Gender Discrimination, as is I worry that much:
 healthyideas.com
 Yet, I do:
 "...Women: Don't despair -- your naturally higher level of body fat protects you from the elements, allows you to bear and shelter children and even perform some physical activities more efficiently.
 ..."
 OUR PILL just may be THE WOMEN'S PILL of the 21st Century:
 Watch Thou Sugar, it makes you nuts ( and some need St Johns' )sometimes. Sometimes THE PILLs approved currently just WON'T FULLY AID and HELP the Whole Person- The Whole Problem, the Better Half of a Couple may need Fat Cell Control more than the other. < X'Cept for ME, LOL) Pills HELPING PEOPLE, Better-Smarter-Faster and LESS SIDE-EFFECT!
 Now The Sides: Each Person is an Individual:MORE CHOICES are NEEDED, IMHO:
 diabetesmonitor.com
 Pepto Bismol, you have to be kiding, Sides Effect will fade in time.
 inciid.org
 You see, I take St Johns' Wart in order to perform morte effectively ( except when I forget, LOL, since 1993; 3 - 4, big herb capsules are best <BTW rather than the studies that showed that mush solid pills are deviated in true amounts of the HERB> pills a day:There must be others like me out there, that is why I am here, in addition to earning income, I am assisting in what I believe in, so JOIN IN, FREEDOM OF CHOICE:
 inciid.org
 ragingbull.com
 ragingbull.com
 ragingbull.com
 All, we better remember that IMMC has 25% of Diabetes Type II and BIOHF does not own 25% of IMMC, IMMC has 25% of BIOHF. This fact is ONE HELL OF A BONUS when a decision in Buying into this NEWTECH is made here. REC- STRONG BYE. POSITION- LONG on any increase value, optioned from now on, just like any new investor. I get paid to write this, BUT I believe in the concept.
 
 Yet, Look at the price/volume that IMMC has done.
 60 days chart at Bigcharts.com shows how we just got the New $2 Level while we had the "E" ON THE Symbol that just dropped of yesterday.
 bigcharts.com
 CHART on CSW shows the one month drop with the E on the Symbol Gap, and the recent recovery:
 chart.canada-stockwatch.com
 We have Eyes don't we. Now read my employers Website click on Immunis Corp:
 and see the chart at the Bottom, much better:
 stockmaster.com
 and News:
 news.stockmaster.com
 and the ASSETS are 13 Mill yet we have to break the Threashold past the minus 4 cents per share EPS, and with The Pipeline, IMHO, we will:
 news.stockmaster.com
 Nov 1999, Cash- 4 Million Dollars almost!
 Chucka-and they reported! SEC Disclosure on my Personal Profile a/c IMMC and CCI at www.brokerrelations.com
 P.S.- The Old Topten Links - I better search the Greatfull Med this weeks at the .gov website seacch to dig up some interesting URLs, Type II - stay turned.
 "
 techstocks.com
 techstocks.com
 siliconinvestor.com
 ? This link is so poped on today- 1 July that I haven't even read it, 2 Million Shares Volume today <7-1>...a desperate "HERE's THE URL" to the ARTICLE on DOW JONES REPORTER STORY on CYTO ...so I scraped the Thread URL...here..for now..Hit this one now - Edit
 Acess To Medical Journals-Gore announced FREE use! Database of medical information-National Library of Medicine. This new service is called "PubMed" and make avail over 9 million Med Jours-from 260+Academic/M. Jours.List by Name,Author/option to read ABSTRACT of NOT complete article.Bet Veep Surfs SI - Edit
 and
 
 American Gov'ntReseach Gratefull Med-Nat'l Library Is it a Ben & Jerry Ice(CherryGarcia) Cream? A Song or a Group? User ID code immediatly; dom or intl users. Cr.Cd or cash prepaid required.CS= mms@nim.nih.gov. There are 8 mill refs+Loansome Doc in Medline CS at www.nnlm.nlm.nih.gov $2.00 avg search - Edit
 An OTC Bulletin Board
 
 igm.nlm.nih.gov
 ChuckaII( Revised From Chucka2) LOL-Lots Of Laughter
 Due Dilly PR is Full:
 PRESS RELEASE
 
 ImmuNis Corp Symbol Change to IMMC
 
 FAIRFIELD,  N.J., Jan 12, The President of ImmuNis Corp. (OTC Bulletin Board:
 IMMCE) and (OTC Symbol IMMC), Colin Leech-Porter, announced today that the
 company has been delayed in filing its first FORM 10. The company anticipates
 the filing to be completed prior to January 25, 2000.
 
 In keeping with the policy of the National Association of Securities Dealers,
 the Shares of ImmuNis Corp will be quoted in the OTC market only.  The daily
 price for the shares may be obtained from Bloomberg Investor Services at
 their web site www.bloomberg.com/. At the  home page enter the company's
 symbol "IMMC" to obtain the  price and trading volume.
 
 Investors without access to the internet or a broker dealer to obtain the
 price of the shares are invited to call our shareholders relations service
 provider YES International at (800) 631-8127.
 
 ImmuNis purchased a 25% interest in the commercial rights to DIAB II in 1998
 for territories outside of Oriental Asia. DIAB II was developed by Biotech
 Holdings Ltd., a Canadian-based pharmaceutical company, which controls the
 worldwide manufacturing and marketing rights to the drug. DIAB II is an
 insulin-receptor sensitizer, a new class of drugs for controlling the
 chronically high blood sugar levels that typify diabetes. DIAB II works by
 improving the patient's ability to utilize both endogenous and injected
 insulin, the hormone that controls blood sugar levels. Adult-Onset Diabetes
 is an illness affecting more than 15 million Americans and more than 150
 million people around the world. The drug -- DIAB II -- provides excellent
 control of diabetes symptoms without the side-effects of many competing
 drugs.
 
 ImmuNis Corp. owns interests and invests in innovative health care modalities
 that address health problems afflicting populations in both developing
 countries and Western nations. The Company's interests may be in the form
 strategic partnerships, direct ownership interest in patents, participation
 in or control of commercial or marketing rights.
 
 Contact Rich Kaiser at YES International Investor Relations Services, (800)
 631-8127.
 
 ---- End Included Message ----..Chuckastartofsomething. To HELP folks, ask your self why won't the FDA make it easy - it is LIFE THREATHENING in some ways - we ( USA folks ) deserve a FASTTRACK APPROVAL on such innovative PILLs, IMHO. The FIGHT STARTS HERE with OUR INFORMATIONAL LINKS! JOIN IN. First the WORLD- THEN THE Americas.
 
 
 |